Ironic fate: Can a banned drug control metal heavies in neurodegenerative diseases?

17Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

In this issue of Neuron, Kaur et al. demonstrate that iron chelation by ferritin transgene or the metal chelator clioquinol prevent oxidative damage and MPTP toxicity in mice. This raises the issue of specific iron chelators or clioquinol for control of oxidative damage in Parkinson's, Alzheimer's, and other neurodegenerative diseases, but not without safety concerns.

Cite

CITATION STYLE

APA

Cole, G. M. (2003, March 27). Ironic fate: Can a banned drug control metal heavies in neurodegenerative diseases? Neuron. Cell Press. https://doi.org/10.1016/S0896-6273(03)00160-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free